Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Share making decision tool, Delegation protocol.
- Who it may be relevant to
- Registry conditions: Acute Cystitis. Basic parameters: 18 years — 65 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool : a Randomised Cluster Trial. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections
Overview
The purpose of this trial is to demonstrate that when treating acute cystitis without risk of complication, pharmacists may use share Decision Making tool to help patients to better understand the stakes of taking antibiotics and adapt the management of the delegation protocol. This will select patients in need of antibiotics and preserve the full-capacities of non-treated one.
Detailed description
Each year, in France, more than 2.000.000 patients visit for a acute cystitis. The literature shows that acute cystitis without risk of complication cause pyelonephritis only on really rare situation, but french delegation protocols to pharmacist ask for systematic antibiotic therapy as soon as the diagnostic is made with the only goal to lowering symptomatology. Studies shows that some informed women would like not to take antibiotics while others studies show us that pain-killers could be as effective as antibiotics on case of low symptomatology.
This study will compare a group following only the French protocols for delegating acute cystitis to the pharmacist with a group using the same protocol, but supplementing it with a shared decision-making tool to determine whether, after being informed of the benefits and risks of this treatment, patients still wish to receive an antibiotic. Targeting instead of systematic prescription will reduce antibiotic consumption.
After diagnostic of acute cystitis to a woman between 18 and 65 years, investigators check if they filing all study criteria and ask for authorization to add them to the study. Then they'll act following their group instruction, and get informations (antibiotic prescription or not, patient socio-demographic criteria). Then patients will be followed by telephone on D14 to know if they've take antibiotics and to obtain the following information: AIA scale, O'Connor Scale, Satisfaction scale, if there has been visit to the emergency room or doctor. Antibiotics delivery on pharmacy will be watch by National assurance number of the included patients
Interventions
- Other Share making decision tool
the experimental group will apply the delegation protocol, but if the protocol recommends antibiotic therapy, the researchers will propose a shared decision using a specific tool to determine with the patient whether to deliver the antibiotic - Other Delegation protocol
the control group will apply the delegation protocol alone
Primary outcome measures
- Dispensing of antibiotic [Time frame: day 14 after inclusion]
Secondary outcome measures (4)
- Activity Impairment Assessment(AIA) scale [Time frame: day 14 after inclusion]
- Satisfaction scale [Time frame: day 14 after inclusion]
- O'Connor scale [Time frame: day 14 after inclusion]
- Medical consultation [Time frame: day 14 after inclusion]
Eligibility criteria
Inclusion criteria
- woman,
- symptom of acute cystitis without risk of complication,
- affiliated to the french public welfare system,
- signed consent.
Exclusion criteria
- anomaly of the urinary canal,
- pregnancy, more than 3 cystitis during the last year,
- cancer,
- immunosuppression,
- hemopathy,
- fever,
- back-pain,
- severe renal failure,
- refuse to give consent and previously participate to the study,
- under guardianship.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
France · 14 centers
- Pharmacie Lemarquis — Aire-sur-l'Adour
- Pharmacie Lafitte — Arès
- CHU de Bordeaux — Bordeaux
- Pharmacie Pattyn Nizard — Caudebec-lès-Elbeuf
- Pharmacie Saint-Jean d'Elbeuf — Elbeuf
- Pharmacie Tranchant — Elbeuf
- Pharmacie du Réolais — La Réole
- Pharmacie de Gascogne — Léguevin
- … and 6 more centers
Identifiers
NCT: NCT07118748 · CHUBX 2024/66